CreditReports.dk
HomeScreen companies

PHARMA-SKAN ApS Financials, key figures and credit report

CVR number: 16275247 Established 1992 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Adelgade 27, 8660 Skanderborg info@pharma-skan.dk tel: 87939091
Gross profit 12 339.9 kDKK FY 2025 -19.2% vs 2024
EBIT 10 141.6 kDKK FY 2025 -28.6% vs 2024
Net debt 318.1 kDKK FY 2025 +104.5% vs 2024
Quick ratio 1.4 FY 2025 -3.5 vs 2024

Company information

Official name
PHARMA-SKAN ApS
Personnel
18 persons
Established
1992
Company form
Private limited company
Industry

Data sources and methodology

The information about PHARMA-SKAN ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About PHARMA-SKAN ApS

PHARMA-SKAN ApS (CVR number: 1627524-7) is a company from SKANDERBORG. The company recorded a gross profit of 12.3 mDKK in 2025. The operating profit was 10.1 mDKK, while net earnings were 7875.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 50.7 %, which can be considered excellent and Return on Equity (ROE) was 56.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 51 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. PHARMA-SKAN ApS's liquidity measured by quick ratio was 1.4 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit12 419.9414 799.7915 308.0515 271.7812 339.94
EBIT11 722.7013 963.5514 565.2414 201.3010 141.63
Net earnings9 069.0010 877.2311 498.3111 288.307 875.19
Shareholders equity total17 003.9718 881.2019 879.5119 167.828 543.01
Balance sheet total (assets)21 111.7623 501.3323 561.4023 309.9716 759.36
Net debt-11 166.31-15 027.49-12 200.90-7 134.41318.10
Profitability
EBIT-%
ROA52.5 %62.8 %62.7 %61.8 %50.7 %
ROE51.9 %60.6 %59.3 %57.8 %56.8 %
ROI66.2 %76.9 %75.3 %73.3 %66.9 %
Economic value added (EVA)8 235.8310 018.4010 402.1110 065.466 935.42
Solvency
Equity ratio80.5 %80.3 %84.4 %82.2 %51.0 %
Gearing1.1 %0.3 %0.3 %25.1 %
Relative net indebtedness %
Liquidity
Quick ratio4.74.75.75.01.4
Current ratio5.35.26.65.82.0
Cash and cash equivalents11 353.8115 078.3012 251.717 134.411 827.95
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
50.7%
Rating 95/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
51.0%
Rating 41/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of PHARMA-SKAN ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated